Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The LEADER trial 28 (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results) studied a 1.8-mg dose in more than 9,000 patients with type 2 diabetes and found the incidence of acute pancreatitis was similar between the liraglutide and placebo groups (0.4% vs 0.5%, respectively)
(pen)
Consider periodic lab checks to track progress on nutrient status
We use this information to design your individualized weight loss program
Medication is only the tip of the iceberg
US$ 23.07
US$ 25.23
US$ 26.41
US$ 26.34
US$ 23.84
US$ 25.37
